- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- January 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Report
- June 2023
- 104 Pages
Global
From €4302EUR$4,450USD£3,698GBP
- Report
- February 2023
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- April 2023
- 180 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- September 2022
- 115 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- September 2022
- 62 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- November 2022
- 175 Pages
Global
From €3480EUR$3,600USD£2,991GBP
- Report
- April 2023
- 156 Pages
Global
€4834EUR$5,000USD£4,155GBP
- Report
- April 2023
- 114 Pages
Global
€3384EUR$3,500USD£2,908GBP
Prednisone is a corticosteroid drug used to treat a variety of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and allergies. It works by reducing inflammation in the airways, which helps to reduce symptoms such as wheezing, coughing, and shortness of breath. Prednisone is available in both oral and injectable forms, and is often prescribed in combination with other medications. It is generally well-tolerated, but can cause side effects such as weight gain, increased appetite, and mood swings.
The Prednisone market is an important part of the larger respiratory drugs market. It is used to treat a wide range of respiratory conditions, and is often prescribed in combination with other medications. It is generally well-tolerated, but can cause side effects.
Some companies in the Prednisone market include Pfizer, Merck, GlaxoSmithKline, and Novartis. Show Less Read more